Hi all
Always interested in Biotechs and considering picking up some ACL for the medium term - looks like there are some interesting times ahead.
Price looks good although the last week has been a little up and down. Recent volumes don't seem staggering for a stock that is close to FDA approval - would have expected the market to have picked up on it by now.
They have around $15m to last them. What is cash burn like?
Is everyone pretty happy with management performance?
Anyone prepared to sum up the opportunity in a reasonably balanced way?
Thanks in advance.
Add to My Watchlist
What is My Watchlist?